Home > Research > Publications & Outputs > Limiting Pseudomonas aeruginosa Biofilm Formati...

Research

Associated organisational units

Electronic data

  • Patenall 2018 accepted manuscript

    Rights statement: Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma Bethany L. Patenall, Hollie Hathaway, Adam C. Sedgwick, Naing T. Thet, George T. Williams, Amber E. Young, Sarah L. Allinson, Robert D. Short, Andrew Toby A. Jenkins pages 269-277 DOI: 10.1615/PlasmaMed.2018028325

    Accepted author manuscript, 911 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

Keywords

View graph of relations

Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma. / Patenall, Bethany L ; Hathaway, Hollie; Sedgwick, Adam C. et al.
In: Plasma Medicine, Vol. 8, No. 3, 30.09.2018, p. 269-277.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Patenall, BL, Hathaway, H, Sedgwick, AC, Thet, NT, Williams, GT, Young, AE, Allinson, SL, Short, RD & Jenkins, ATA 2018, 'Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma', Plasma Medicine, vol. 8, no. 3, pp. 269-277. https://doi.org/10.1615/PlasmaMed.2018028325

APA

Patenall, B. L., Hathaway, H., Sedgwick, A. C., Thet, N. T., Williams, G. T., Young, A. E., Allinson, S. L., Short, R. D., & Jenkins, A. T. A. (2018). Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma. Plasma Medicine, 8(3), 269-277. https://doi.org/10.1615/PlasmaMed.2018028325

Vancouver

Patenall BL, Hathaway H, Sedgwick AC, Thet NT, Williams GT, Young AE et al. Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma. Plasma Medicine. 2018 Sept 30;8(3):269-277. doi: 10.1615/PlasmaMed.2018028325

Author

Patenall, Bethany L ; Hathaway, Hollie ; Sedgwick, Adam C. et al. / Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma. In: Plasma Medicine. 2018 ; Vol. 8, No. 3. pp. 269-277.

Bibtex

@article{0a162df8862346d38597d69638ec66ff,
title = "Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma",
abstract = "We investigate the ability to disrupt and limit growth biofilms of Pseudomonas aeruginosa using application of cold atmospheric pressure (CAP) plasma. The effect of the bio-film's exposure to a helium (CAP) jet was assessed at varying time points during biofilm maturation. Results showed that the amount of time during biofilm growth that CAP pressure was applied has a crucial role on the ability of biofilms to mature and recover after CAP exposure. Intervention during the early stages of biofilm formation (0-8 h) results in a 4-5-log reduction in viable bacterial cells (measured at 24 h of incubation) relative to untreated biofilms. However, CAP treatment of biofilm at 12 h and above only results in a 2-log reduction in viable cells. This has potentially important implications for future clinical application of CAP to treat infected wounds. ",
keywords = "plasma, biofilm, Pseudomonas aeruginosa",
author = "Patenall, {Bethany L} and Hollie Hathaway and Sedgwick, {Adam C.} and Thet, {Naing T.} and Williams, {George T.} and Young, {Amber E.} and Allinson, {Sarah Louise} and Short, {Robert D} and Jenkins, {A. Toby A.}",
note = "Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma Bethany L. Patenall, Hollie Hathaway, Adam C. Sedgwick, Naing T. Thet, George T. Williams, Amber E. Young, Sarah L. Allinson, Robert D. Short, Andrew Toby A. Jenkins pages 269-277 DOI: 10.1615/PlasmaMed.2018028325",
year = "2018",
month = sep,
day = "30",
doi = "10.1615/PlasmaMed.2018028325",
language = "English",
volume = "8",
pages = "269--277",
journal = "Plasma Medicine",
issn = "1947-5764",
publisher = "Begell House Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma

AU - Patenall, Bethany L

AU - Hathaway, Hollie

AU - Sedgwick, Adam C.

AU - Thet, Naing T.

AU - Williams, George T.

AU - Young, Amber E.

AU - Allinson, Sarah Louise

AU - Short, Robert D

AU - Jenkins, A. Toby A.

N1 - Limiting Pseudomonas aeruginosa Biofilm Formation Using Cold Atmospheric Pressure Plasma Bethany L. Patenall, Hollie Hathaway, Adam C. Sedgwick, Naing T. Thet, George T. Williams, Amber E. Young, Sarah L. Allinson, Robert D. Short, Andrew Toby A. Jenkins pages 269-277 DOI: 10.1615/PlasmaMed.2018028325

PY - 2018/9/30

Y1 - 2018/9/30

N2 - We investigate the ability to disrupt and limit growth biofilms of Pseudomonas aeruginosa using application of cold atmospheric pressure (CAP) plasma. The effect of the bio-film's exposure to a helium (CAP) jet was assessed at varying time points during biofilm maturation. Results showed that the amount of time during biofilm growth that CAP pressure was applied has a crucial role on the ability of biofilms to mature and recover after CAP exposure. Intervention during the early stages of biofilm formation (0-8 h) results in a 4-5-log reduction in viable bacterial cells (measured at 24 h of incubation) relative to untreated biofilms. However, CAP treatment of biofilm at 12 h and above only results in a 2-log reduction in viable cells. This has potentially important implications for future clinical application of CAP to treat infected wounds.

AB - We investigate the ability to disrupt and limit growth biofilms of Pseudomonas aeruginosa using application of cold atmospheric pressure (CAP) plasma. The effect of the bio-film's exposure to a helium (CAP) jet was assessed at varying time points during biofilm maturation. Results showed that the amount of time during biofilm growth that CAP pressure was applied has a crucial role on the ability of biofilms to mature and recover after CAP exposure. Intervention during the early stages of biofilm formation (0-8 h) results in a 4-5-log reduction in viable bacterial cells (measured at 24 h of incubation) relative to untreated biofilms. However, CAP treatment of biofilm at 12 h and above only results in a 2-log reduction in viable cells. This has potentially important implications for future clinical application of CAP to treat infected wounds.

KW - plasma

KW - biofilm

KW - Pseudomonas aeruginosa

U2 - 10.1615/PlasmaMed.2018028325

DO - 10.1615/PlasmaMed.2018028325

M3 - Journal article

VL - 8

SP - 269

EP - 277

JO - Plasma Medicine

JF - Plasma Medicine

SN - 1947-5764

IS - 3

ER -